GCS-100-CS-4002

· La Jolla Pharmaceutical Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GCS-100-CS-4002, covering 2016-12-26 to 2016-12-26. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Extension Study of Study GCS-100-CS-4002 [Phase 2]